Joe is going into the Corona virus hype, not because it
Joe is going into the Corona virus hype, not because it will cause the pps to rise, he is doing it because generex has the know how (or at least they did at one time) to make a whole bunch of synthetic vaccines, cheaply and fast, if their research were to be infused with a few million dollars.....
i think the announcement of the CC and having Corona virus as the number one initiative on the corporate update is only a sign of something big ready to break into the scene....
2019-nCOV coronavirus initiatives
5/2 dividends in Generex and NuGenerex Immuno-Oncology
ALTuCELL Closing
S1 funding update
(cont....)....
call me an optimist but i really feel that this CC is going to be much different from previous ones.....the timing first of all, one day before the record date, guaranteed by generex.....the series of events leading to the payment of the dividend.....the short pay date on the 24 th....so many irons in the fire....ngio, nasdaq, s1, altucell and other initiatives....
and the pessimist in me will see that they are going to rehash all the stuff they have been talking about for the last 6 months.....
....but maybe, just maybe.....some light at the end of tunnel...
2
Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...
Continue Reading
AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...
Continue Reading
History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...
Continue Reading
A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...
Continue Reading
Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....
Continue Reading
Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...
Continue Reading
Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...
Continue Reading
Top 5 Most Recently Viewed Articles
Fangzhou's AI-Driven Weight Management Innovation Unveiled In a landmark event in Beijing, the "Healthy China: AI + Weight Management" Innovation Symposium captured the attention of healthcare professionals and industry leaders. Hosted by Fangzhou Inc. (06086.HK), a pioneer in AI technologies for healthcare, the symposium underscored the importance of integrating...
Continue Reading
MGI Partners with Negedia for Enhanced Genomic Sequencing Understanding gene expression in the spatial context of tissues is a critical aspect of studying rare diseases and advancing precision medicine. Innovative technologies like high-throughput sequencing and spatial transcriptomics (STOmics) are revolutionizing our biological and molecular comprehension of diverse...
Continue Reading
SEO Builder Achieves Remarkable Growth Milestone SEO Builder, a prominent link-building agency based in the UK, is thrilled to announce that it has successfully surpassed the milestone of serving its 2,000th customer. Since launching in 2018, the company has achieved consistent growth, positioning itself as a trusted authority in the realm of local citation building....
Continue Reading
Gilbane Marks the Start of Lionsgate Studio Construction In a remarkable event, Gilbane Building officially commenced construction of Lionsgate Newark, a groundbreaking project that promises to reshape the film and television landscape in the region. The studio, spanning nearly 300,000 square feet, represents the first purpose-built facility in New Jersey tailored...
Continue Reading
Major Contract Awarded to KBR for Astronaut Health KBR has received an impressive contract valued at approximately $2.459 billion from NASA to bolster astronaut health and performance during space missions. This significant achievement showcases KBR's existing partnerships and expertise in supporting essential health and safety measures for astronauts, further emphasizing...
Continue Reading